Controlling protein activity in living cells using light and nanoparticles
Optical Control of Protein Activity in Live Cells by Plasmon Assisted Light Inactivation
This study is exploring a new way to use lasers and tiny particles to control how proteins work in living cells, which could help improve tests and treatments for health issues related to protein function.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Dallas NIH-funded |
| Lab location | 1 site (Richardson, United States) |
| Project ID | NIH-10698186 on NIH RePORTER |
What this research studies
This research investigates how laser-plasmonic nanoparticle interactions can be used to manipulate protein activity in live cells. By employing a technique called plasmon-assisted light inactivation (PALI), the researchers aim to use pulsed laser heating to unfold and denature proteins near the surface of nanoparticles. This innovative approach allows for precise control over protein functions, which could lead to new diagnostic methods and therapeutic strategies. Patients may benefit from advancements in understanding and treating conditions related to protein signaling and function.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with conditions related to protein signaling, such as certain cancers or neurological disorders.
Not a fit: Patients with conditions unrelated to protein activity or those who do not respond to protein-targeted therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in the treatment of diseases linked to protein dysfunction.
How similar studies have performed: Other research has shown promise in using optical tools for protein manipulation, indicating that this approach could be a significant advancement in the field.
Where this research is happening
Richardson, United States
- University of Texas Dallas — Richardson, United States (Active)
Researchers
- Principal investigator: Qin, Zhenpeng — University of Texas Dallas
- Study coordinator: Qin, Zhenpeng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.